Rasagiline Mesylate
Links shared publicly online about this topic
Watson seeks FDA approval to market rasagiline mesylate tablets
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market rasagiline mesylate 0.5 and 1.0 mg tablets.” View full resource at news-medical.net
Most Recently Shared on October 6, 2010 at 6:49 am By:
Watson seeks FDA approval to market rasagiline mesylate tablets: Watson Pharmaceuticals, Inc. today confirmed that... http://bit.ly/c4479C
Monoamine Oxidase Type B Inhibitors in the Treatment of Early Parkinson's Disease | Neurology
touchneurology.com — “Parkinson's disease, monoamine oxidase type B (MAO-B) inhibitors, rasagiline, selegiline, Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP) study, Rasagiline Mesylate (TVP-1012) in Early Monotherapy for PD Outpatients (TEMPO)” View full resource at touchneurology.com
Most Recently Shared on October 24, 2010 at 12:15 pm By:
touchNEURO Health Site and Neurology
Monoamine Oxidase Type B treatment - http://ow.ly/2V5ab
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
News-Medical.Net
Medical News from Around the World
-
touchNEURO
Touch NEUROLOGY enables time-pressured physicians to stay abreast of key advances in the neurological industry. Including info on disorders, symptoms & diseases
Advertisement
